Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg BID versus clarithromycin 500 mg BID

This publication has 16 references indexed in Scilit:

• Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory season
  Diagnostic Microbiology and Infectious Disease, 1997
• Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis
  Clinical Therapeutics, 1997
• Results of the Alexander Project: A continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens
  Diagnostic Microbiology and Infectious Disease, 1996
• A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project
  Journal of Antimicrobial Chemotherapy, 1996
• Epidemiology and Treatment of Chronic Bronchitis and Its Exacerbations
  Chest, 1995
• Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force
  European Respiratory Journal, 1995
• Antibiotics in Chronic Obstructive Pulmonary Disease Exacerbations
  JAMA, 1995
• Prevalence and Correlates of Respiratory Symptoms and Disease in the Elderly
  Chest, 1994
• Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
  Annals of Internal Medicine, 1987
• Quantitative sputum gram stains in chronic bronchial disease
  Lung, 1979